Company intelligence / Profile preview

Kubota Pharmaceutical Holdings

Minato-ku, Tokyo-to, Japankubotaholdings.co.jp ↗

Ownership: Private
Development stage: Commercial

Overview

Emixustat HCl completed a Phase 3 trial in Stargardt disease but did not meet the primary endpoint; however, further analysis showed efficacy in early-stage patients, and development strategy is being reconsidered. The company’s wearable myopia control device, Kubota Glass™, has been soft-launched in the US and Japan. Remote retinal monitoring devices are under development with licensing agreements for global distribution.

Therapeutic areas: Ophthalmology
Modalities: Small moleculeDeviceNanotechnology-based device
Industry: Biotech

Drug pipeline

1 asset

Kubota Glass

Commercial

Indications: Vision disorders

Partnerships

AUROLAB/Aravind Eye Care System – exclusive license agreement to develop, manufacture, supply and distribute eyeMO in South Asia and select emerging marketsTRISH/NASA – collaboration on compact OCT device development for spaceflight applications

Beyond the preview

Go deeper on Kubota Pharmaceutical Holdings.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kubota Pharmaceutical Holdings.

Explore the full profile